The UK biotechnology sector is undergoing significant change as 2024 ends, driven by increased corporate venture capital and private equity funding. This financial boost has spurred activity, with investments in startups and scaling initiatives creating new jobs despite lingering post-COVID challenges.
Stay informed with the latest insights on labour market shifts, hiring patterns, and industry-specific analytics. Our Snapshots highlight key developments across multiple sectors, helping you navigate the evolving recruitment landscape.
Stay informed with the latest insights on labour market shifts, hiring patterns, and industry-specific analytics. Our Snapshots highlight key developments across multiple sectors, helping you navigate the evolving recruitment landscape.
Stay informed with the latest insights on labour market shifts, hiring patterns, and industry-specific analytics. Our Snapshots highlight key developments across multiple sectors, helping you navigate the evolving recruitment landscape.
The revision by the OECD that Britain’s GDP growth for next year will be higher than initially thought will be welcome news to Rachel Reeves and Kier Starmer. Indeed, the increase has been from 0.4% when forecast in May, to 1.1% now. At a time when the Government are facing acrimony over their budget, and business confidence is deteriorating, it is important to understand though, that the reason why the forecast has been lifted is due to the planned investments into the public sector.
